DawaDose, a Jordan-founded pharmaceutical e-commerce startup, has closed its pre-seed funding round with participation from angel investors, marking a major step in its regional growth journey. The amount raised remains undisclosed. Alongside the investment, the company announced the relocation of its headquarters to Saudi Arabia, establishing the Kingdom as its new base for operations and expansion.
Founded in 2019 by Rushdi Abdalghani (Co-Founder & CEO) and Osama Almabroum (Co-Founder & Business Development Lead), DawaDose is building the region’s first fully integrated B2C and B2B pharmaceutical ecosystem. The platform connects pharmacies, wholesalers, and consumers through secure, efficient, and accessible digital solutions, fully aligned with Saudi Arabia’s Vision 2030 goals.
“This funding is not just capital; it’s trust — trust in our vision to digitise healthcare access across the Middle East, starting with Saudi Arabia,” said Abdalghani. Almabroum added, “We are building DawaDose as a Saudi company with a global outlook. This is just the first step toward reshaping pharmaceutical e-commerce in the region.”
The fresh capital will accelerate the development of Arabic-first AI-powered digital tools, expand partnerships with pharmacies and distributors, and prepare the company for regional scale-up across Saudi Arabia and the wider Gulf market.
